Source:http://linkedlifedata.com/resource/pubmed/id/18021283
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-10
|
pubmed:abstractText |
Numerous studies have shown that protocol biopsies have predictive power. We retrospectively examined the histologic findings and C4d staining in 89 protocol biopsies from 48 ABO-incompatible (ABO-I) transplant recipients, and compared the results with those of 250 controls from 133 ABO-compatible (ABO-C) transplant recipients given equivalent maintenance immunosuppression. Others have shown that subclinical rejection (borderline and grade I) in ABO-C grafts decreased gradually after transplantation. In our study, however, subclinical rejection in the ABO-I grafts was detected in 10%, 14% and 28% at 1, 3 and 6-12 months, respectively. At 6-12 months, mild tubular atrophy was more common in the ABO-C grafts whereas the incidence of transplant glomerulopathy did not differ between the two groups (ABO-C: 7%; ABO-I: 15%; p = 0.57). In the ABO-I transplants, risk factors for transplant glomerulopathy in univariate analysis were positive panel reactivity (relative risk, 45.0; p < 0.01) and a prior history of antibody-mediated rejection (relative risk, 17.9; p = 0.01). Furthermore, C4d deposition in the peritubular capillaries was detected in 94%, with diffuse staining in 66%. This deposition, however, was not linked to antibody-mediated rejection. We conclude that, in the ABO-I kidney transplantation setting, detection of C4d alone in protocol biopsies might not have any diagnostic or therapeutic relevance.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1600-6143
|
pubmed:author |
pubmed-author:HoritaSS,
pubmed-author:IidaSS,
pubmed-author:IshidaHH,
pubmed-author:NakayamaHH,
pubmed-author:OmotoKK,
pubmed-author:SetoguchiKK,
pubmed-author:SetoguchiSS,
pubmed-author:ShimizuTT,
pubmed-author:ShimmuraHH,
pubmed-author:ShirakawaHH,
pubmed-author:TanabeKK,
pubmed-author:TokiDD,
pubmed-author:TokumotoTT,
pubmed-author:YamaguchiYY
|
pubmed:issnType |
Electronic
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
86-94
|
pubmed:meshHeading |
pubmed-meshheading:18021283-ABO Blood-Group System,
pubmed-meshheading:18021283-Adult,
pubmed-meshheading:18021283-Biopsy,
pubmed-meshheading:18021283-Blood Group Incompatibility,
pubmed-meshheading:18021283-Complement C4b,
pubmed-meshheading:18021283-Female,
pubmed-meshheading:18021283-Graft Rejection,
pubmed-meshheading:18021283-Humans,
pubmed-meshheading:18021283-Kidney,
pubmed-meshheading:18021283-Kidney Transplantation,
pubmed-meshheading:18021283-Male,
pubmed-meshheading:18021283-Middle Aged,
pubmed-meshheading:18021283-Retrospective Studies
|
pubmed:year |
2008
|
pubmed:articleTitle |
Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation.
|
pubmed:affiliation |
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan. setoguchi-jua@umin.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|